Fidelity Investments’s Accretive Health AH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-14,589,861
Closed -$117M 2889
2014
Q1
$117M Buy
14,589,861
+1,767,285
+14% +$15.6M 0.02% 898
2013
Q4
$117M Buy
12,822,576
+2,507,674
+24% +$21.6M 0.02% 878
2013
Q3
$94.1M Sell
10,314,902
-849,637
-8% -$8.45M 0.01% 973
2013
Q2
$121M Buy
+11,164,539
New +$117M 0.02% 828

Other funds holding AH

Fidelity Investments's AH Position: Q2 2014 in Review

Fidelity Investments sold out of Accretive Health (AH) in Q2 2014, closing a stake of 14,589,861 shares — an estimated $117M sold.

Fidelity Investments first reported a position in AH in Q2 2013 and held it in 4 quarters. The position peaked at $121M in Q2 2013. 12 funds tracked by Wall St. Rank hold AH as of Q2 2014.

  • Fidelity Investments reported no remaining Accretive Health position as of Q2 2014 after selling out during the quarter.
  • Fidelity Investments sold 14,589,861 Accretive Health shares in Q2 2014, an estimated $117M.
  • Fidelity Investments first reported a position in Accretive Health in Q2 2013 and held it in 4 quarters.
  • Fidelity Investments's Accretive Health position peaked at $121M in Q2 2013.
  • 12 funds tracked by Wall St. Rank held Accretive Health as of Q2 2014.

Based on Fidelity Investments's 13F filing for Q2 2014, filed 14 Aug 2014.